Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to 0.15.

  • Indivior Pharmaceuticals' Equity Ratio changed N/A to 0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15, marking a year-over-year change of. This contributed to the annual value of 0.26 for FY2024, which is 14466.68% down from last year.
  • Indivior Pharmaceuticals' Equity Ratio amounted to 0.15 in Q3 2025.
  • Over the past 5 years, Indivior Pharmaceuticals' Equity Ratio peaked at 0.07 during Q2 2023, and registered a low of 0.26 during Q4 2024.
  • Moreover, its 4-year median value for Equity Ratio was 0.13 (2025), whereas its average is 0.1.
  • Its Equity Ratio has fluctuated over the past 5 years, first plummeted by 14466.68% in 2024, then crashed by 311167.27% in 2025.
  • Indivior Pharmaceuticals' Equity Ratio (Quarter) stood at 0.03 in 2022, then plummeted by 463.04% to 0.1 in 2023, then plummeted by 144.67% to 0.26 in 2024, then surged by 42.91% to 0.15 in 2025.
  • Its last three reported values are 0.15 in Q3 2025, 0.18 for Q2 2025, and 0.21 during Q1 2025.